Rhythm Pharmaceuticals (FRA:1RV) Other Current Liabilities : €7.55 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Rhythm Pharmaceuticals Other Current Liabilities?

Rhythm Pharmaceuticals's other current liabilities for the quarter that ended in Mar. 2024 was €7.55 Mil.

Rhythm Pharmaceuticals's quarterly other current liabilities increased from Sep. 2023 (€3.52 Mil) to Dec. 2023 (€4.96 Mil) and increased from Dec. 2023 (€4.96 Mil) to Mar. 2024 (€7.55 Mil).

Rhythm Pharmaceuticals's annual other current liabilities increased from Dec. 2021 (€0.71 Mil) to Dec. 2022 (€2.28 Mil) and increased from Dec. 2022 (€2.28 Mil) to Dec. 2023 (€4.96 Mil).

Rhythm Pharmaceuticals Other Current Liabilities Historical Data

The historical data trend for Rhythm Pharmaceuticals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Pharmaceuticals Other Current Liabilities Chart

Rhythm Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Rhythm Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Rhythm Pharmaceuticals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Rhythm Pharmaceuticals Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Rhythm Pharmaceuticals's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Pharmaceuticals (FRA:1RV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rhythm Pharmaceuticals Inc (FRA:1RV) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

RYTM:USA RYTM:Mexico 1RV:Germany

Address

222 Berkeley Street, 12th Floor, Boston, MA, USA, 02116

Website

http://www.rhythmtx.com

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies.

Rhythm Pharmaceuticals (FRA:1RV) Headlines

No Headlines